loading

Ocular Therapeutix Inc 주식(OCUL)의 최신 뉴스

pulisher
08:29 AM

Ocular Therapeutix reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

08:29 AM
pulisher
07:54 AM

Saturn V Capital Management LP Purchases 130,385 Shares of Ocular Therapeutix, Inc. $OCUL - MarketBeat

07:54 AM
pulisher
07:02 AM

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

07:02 AM
pulisher
07:00 AM

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.

07:00 AM
pulisher
02:09 AM

What sentiment indicators say about Ocular Therapeutix Inc. stockWeekly Trade Recap & High Return Trade Opportunity Guides - Newser

02:09 AM
pulisher
Dec 04, 2025

How Ocular Therapeutix Inc. stock reacts to inflationary pressuresDollar Strength & Reliable Breakout Forecasts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How forex fluctuations impact Ocular Therapeutix Inc. (0OT) stockJuly 2025 PostEarnings & Weekly Top Gainers Trade List - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

OCUL: Phase III trials target a first-in-class superiority label and durable retinal disease therapy - TradingView

Dec 03, 2025
pulisher
Dec 02, 2025

Discipline and Rules-Based Execution in OCUL Response - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

Is Ocular Therapeutix Inc. stock cheap compared to fundamentals2025 Year in Review & Stepwise Trade Signal Guides - Newser

Dec 02, 2025
pulisher
Nov 27, 2025

Hedge Fund Bets: What is the fair value of Ocular Therapeutix Inc. stock now2025 Sector Review & Smart Swing Trading Alerts - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

Highs Report: Why analysts raise outlook for Ocular Therapeutix Inc. (0OT) stock2025 Volatility Report & Safe Swing Trade Setup Alerts - moha.gov.vn

Nov 26, 2025
pulisher
Nov 26, 2025

Ocular Therapeutix CEO Dugel sells $235k in stock By Investing.com - Investing.com Australia

Nov 26, 2025
pulisher
Nov 25, 2025

How HELIOS-3 Phase 3 Trial Enrollment at Ocular Therapeutix (OCUL) Has Changed Its Investment Story - Sahm

Nov 25, 2025
pulisher
Nov 25, 2025

OCUL: HC Wainwright & Co. Reiterates Buy Rating with $19 Price T - GuruFocus

Nov 25, 2025
pulisher
Nov 25, 2025

HC Wainwright & Co. Reiterates Ocular Therapeutix (OCUL) Buy Recommendation - Nasdaq

Nov 25, 2025
pulisher
Nov 24, 2025

Ocular Therapeutix Begins Phase 3 Registrational Program to Potentially Treat Non-Proliferative Diabetic Retinopathy - marketscreener.com

Nov 24, 2025
pulisher
Nov 24, 2025

Ocular Therapeutix (OCUL) Advances Diabetic Retinopathy Treatmen - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR - The Manila Times

Nov 24, 2025
pulisher
Nov 22, 2025

Ocular Therapeutix Reports Q3 2025 Financial Results - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Behavioral Patterns of OCUL and Institutional Flows - news.stocktradersdaily.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Ocular Therapeutix Inc. (0OT) stock remains stableIndex Update & Reliable Intraday Trade Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Ocular Therapeutix Inc. stock see PE expansionWeekly Profit Summary & Weekly Top Performers Watchlists - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Ocular Therapeutix Inc. stock a safe haven assetJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Ocular Therapeutix Inc. stock pay special dividendsWeekly Investment Recap & Entry Point Confirmation Signals - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet - sharewise.com

Nov 20, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 06:23:38 - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why analysts recommend Ocular Therapeutix Inc. (0OT) stockInflation Watch & Technical Pattern Alert System - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Ocular Therapeutix Inc. (0OT) stock stays on top picksRate Hike & High Return Stock Watch Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is this a good reentry point in Ocular Therapeutix Inc.2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Ocular Therapeutix Inc. stock near bottom after declineJuly 2025 Institutional & Intraday High Probability Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Ocular Therapeutix Inc. stock see insider buyingSell Signal & Long-Term Safe Investment Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 13:52:30 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Ocular Therapeutix Inc. (0OT) stock could be top winner2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Ocular Therapeutix Inc. stock deliver consistent dividendsQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Comparing Ocular Therapeutix Inc. in custom built stock radarsStop Loss & Growth Focused Stock Pick Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Ocular Therapeutix Inc. stock go up soonMarket Trend Summary & Detailed Earnings Play Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Ocular Therapeutix (OCUL) Soars 5% Ahead of Health Conferences - MSN

Nov 19, 2025
$39.05
price down icon 0.29%
$31.89
price down icon 0.34%
$100.21
price down icon 0.18%
$96.34
price up icon 0.67%
biotechnology ONC
$319.27
price down icon 3.53%
$205.23
price up icon 0.18%
자본화:     |  볼륨(24시간):